British scientists took a “major step forward” in identifying a set of 10 proteins in the blood that can predict the onset of Alzheimer’s disease and prevent the emergence of the symptoms.
“Major Step” against Alzheimer’s disease
After a decade of research, scientists at Oxford University and King’s College London revealed a preventive measure so that drug medication could target the disease before the symptoms appear.
“We want to be able to identify people to enter clinical trials earlier than they currently do and that’s really what we’ve been aiming at,” according to lead researcher Prof. Simon Lovestone from the University of Oxford.
Published in the journal Alzheimer’s & Dementia, the study, which involved 1,000 respondents, would be used to enhance trials for new dementia medications.
Not ready for doctor’s surgeries
Some experts, however, warned that the test was still inappropriate for doctor’s surgeries.
“[It] will take several years and need many more patients before we can be certain these tests are suitable for routine clinical use, that process can start fairly quickly now,” said Dr. Ian Pike, chief operating officer at Proteome Sciences.
Previous research into treatments for Alzheimer’s disease had been in troubled waters. From 2002 to 2012, there are 99.6% failed trials aimed at preventing or reversing the disease.